AEMD Stock Analysis: Buy, Sell, or Hold?
AEMD - AETHLON MEDICAL INC
$2.28
-0.12 (-5.00%)
▼
5d:
-17.99%
30d:
+304.47%
90d:
-25.73%
WAIT
LOW Confidence
Analysis Updated: Aug 26, 2026 12:00 AM ET
Earnings: Aug 13, 2026
0d
Get Alerted When AEMD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: AEMD is down 18.0% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: AEMD is down 18.0% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: AEMD is currently trading at $2.28, which is considered fair relative to its 30-day fair value range of $0.85 to $3.15.
Technical Outlook: Technically, AEMD is in a uptrend. The price is currently testing key support at $2.22. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 5.0% recently.
Market Sentiment: AEMD scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $13.25 (+481.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, AEMD is in a uptrend. The price is currently testing key support at $2.22. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 5.0% recently.
Market Sentiment: AEMD scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $13.25 (+481.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$0.85 -
$3.15
Company Quality Score
38/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
44.7%
All Signals
- NEUTRAL: Price in fair range
- BEARISH: Weak technical setup (15/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-5.0%)
- BULLISH: Trading 481.1% below Wall St target ($13.25)
- WARNING: Composite score 38/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$0.85 -
$3.15
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$2.22
Resistance Level
$3.11
Current Trend
Uptrend
Technical data as of
Aug 26, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-2.33
Wall Street Target
$13.25
(+481.1%)
Revenue Growth (YoY)
4278.2%
Share & Embed Analysis
Last updated: August 26, 2026 6:22 PM ET
Data refreshes hourly during market hours. Next update: 7:22 PM
Data refreshes hourly during market hours. Next update: 7:22 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is AEMD showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$63 | 46 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$383 | 61 BUY |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$172 | 57 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$94 | 36 SELL |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$120 | 39 SELL |
